113 related articles for article (PubMed ID: 8618619)
21. Management of asymptomatic left ventricular dysfunction.
Haas GJ
Cleve Clin J Med; 2001 Mar; 68(3):249-55. PubMed ID: 11263853
[TBL] [Abstract][Full Text] [Related]
22. Managing patients with heart failure: the reality of clinical practice.
Squire I
Eur Heart J; 2005 Dec; 26(24):2611-3. PubMed ID: 16219652
[No Abstract] [Full Text] [Related]
23. What can we learn from Europe?
Swedberg K
Heart; 2005 May; 91 Suppl 2(Suppl 2):ii21-3; discussion ii31, ii43-8. PubMed ID: 15831604
[TBL] [Abstract][Full Text] [Related]
24. [Therapeutic management of heart failure and left ventricular dysfunction following acute myocardial infarction in French intensive care units].
Cambou JP; Vicaut E; Papadopoulos-Degrandsart A; Danchin N
Ann Cardiol Angeiol (Paris); 2007 Jan; 56(1):36-41. PubMed ID: 17343037
[TBL] [Abstract][Full Text] [Related]
25. [Relationship between myocardial ischemia and left ventricular dysfunction].
Z Kardiol; 1994 Oct; 83(10 Suppl):1-8. PubMed ID: 9131100
[No Abstract] [Full Text] [Related]
26. Beta-adrenergic blocking agents or angiotensin-converting enzyme inhibitors, or both, for postinfarction patients with left ventricular dysfunction.
O'Rourke RA
J Am Coll Cardiol; 1997 Feb; 29(2):237-9. PubMed ID: 9014972
[No Abstract] [Full Text] [Related]
27. Effect of ACE inhibitor trandolapril on life expectancy of patients with reduced left-ventricular function after acute myocardial infarction. TRACE Study Group. Trandolapril Cardiac Evaluation.
Torp-Pedersen C; Køber L
Lancet; 1999 Jul; 354(9172):9-12. PubMed ID: 10406358
[TBL] [Abstract][Full Text] [Related]
28. [What is the appropriate treatment for myocardial infarction with left ventricular dysfunction?].
Cohen-Solal A; Himbert D; Caviezel B; Laperche T; Gourgon R
Ann Cardiol Angeiol (Paris); 1994 Nov; 43(9):515-8. PubMed ID: 7864555
[TBL] [Abstract][Full Text] [Related]
29. Angiotensin-converting enzyme inhibitors, inhibition of brain and peripheral angiotensin-converting enzymes, and left ventricular dysfunction in rats after myocardial infarction.
Ahmad M; White R; Tan J; Huang BS; Leenen FH
J Cardiovasc Pharmacol; 2008 Jun; 51(6):565-72. PubMed ID: 18496146
[TBL] [Abstract][Full Text] [Related]
30. HFSA guidelines for management of patients with heart failure caused by left ventricular systolic dysfunction--pharmacological approaches. Heart Failure Society of America.
Pharmacotherapy; 2000 May; 20(5):495-522. PubMed ID: 10809338
[No Abstract] [Full Text] [Related]
31. [Angiotensin-converting enzyme inhibitors. Principles and rules of their use].
Juillière Y
Rev Prat; 2001 Sep; 51(14):1601-7. PubMed ID: 11757278
[No Abstract] [Full Text] [Related]
32. ACE inhibitors after myocardial infarction.
Jackson G
Br J Clin Pract; 1995; 49(4):171. PubMed ID: 7547152
[No Abstract] [Full Text] [Related]
33. [Neurohumoral systems escape control. Heart failure symptoms even once--long-term high risk prognosis].
MMW Fortschr Med; 2005 Jul; 147(27-28):45. PubMed ID: 16041943
[No Abstract] [Full Text] [Related]
34. Acute blood pressure response to trandolapril and captopril in patients with left ventricular dysfunction after acute myocardial infarction.
Weber S; Vaur L; Ounnoughene Z; Schwob J; Dubroca I; Normand J; Etienne S; Charbonnier B
Am Heart J; 2002 Feb; 143(2):313-8. PubMed ID: 11835037
[TBL] [Abstract][Full Text] [Related]
35. Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE Study Group, Trandolapril Cardiac Event.
Gustafsson F; Torp-Pedersen C; Køber L; Hildebrandt P
J Hypertens; 1997 Jul; 15(7):793-8. PubMed ID: 9222948
[TBL] [Abstract][Full Text] [Related]
36. Effect of the angiotensin-converting enzyme inhibitor trandolapril on mortality and morbidity in diabetic patients with left ventricular dysfunction after acute myocardial infarction. Trace Study Group.
Gustafsson I; Torp-Pedersen C; Køber L; Gustafsson F; Hildebrandt P
J Am Coll Cardiol; 1999 Jul; 34(1):83-9. PubMed ID: 10399995
[TBL] [Abstract][Full Text] [Related]
37. Long-term treatment with trandolapril opposes cardiac remodeling and prolongs survival after myocardial infarction in rats.
Richer C; Mulder P; Fornes P; Domergue V; Heudes D; Giudicelli JF
J Cardiovasc Pharmacol; 1992 Jul; 20(1):147-56. PubMed ID: 1383624
[TBL] [Abstract][Full Text] [Related]
38. Effect of beta blockers alone, of angiotensin-converting enzyme inhibitors alone, and of beta blockers plus angiotensin-converting enzyme inhibitors on new coronary events and on congestive heart failure in older persons with healed myocardial infarcts and asymptomatic left ventricular systolic dysfunction.
Aronow WS; Ahn C; Kronzon I
Am J Cardiol; 2001 Dec; 88(11):1298-300. PubMed ID: 11728359
[No Abstract] [Full Text] [Related]
39. Delayed recovery of left ventricular systolic dysfunction: ''give time to medical therapy''.
Ennezat PV; Gonin X; Darchis J; De Groote P; Lamblin N; Bauters C; Lejemtel T; Asseman P
Minerva Cardioangiol; 2007 Jun; 55(3):426-7. PubMed ID: 17534261
[No Abstract] [Full Text] [Related]
40. The angiotensin converting enzyme inhibitor trandolapril has neutral effect on exercise tolerance or functional class in patients with myocardial infarction and reduced left ventricular systolic function.
Abdulla J; Burchardt H; Z Abildstrøm S; Køber L; Torp-Pedersen C;
Eur Heart J; 2003 Dec; 24(23):2116-22. PubMed ID: 14643272
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
